24Jul
23Jul
Aircuity Upgrades Dashboard with New Analytics Features
Aircuity, creator of measurably better environments, announces a redesigned analytics dashboard with many new features making it even easier to intelligently manage your buildings’ portfolio. Many of the new features were designed to analyze and display indoor environmental quality (IEQ) data making Aircuity’s dashboard a critical part of a healthy building strategy. Read more >>
16Jul
sam® Dramatically Improves the Treatment of Soft Tissue, Arthritis and Joint Issues Without Requiring Surgery or Pain Medication
sam® provides effective and safe treatment of soft tissue, arthritis and joint issues without the need for surgery or pain medication. The wearable device does so by stimulating blood flow for several hours per day to a localized region, delivering a powerful flow of nutrients to the site of an injury. Read more >>
15Jul
FDA greenlights KnipBio single-cell protein ingredient for shrimp diets
Massachusetts-based biotechnology company KnipBio received its second Generally Recognized As Safe (GRAS) approval from the US Food and Drug Administration (FDA) to use its single-cell protein meal in shrimp feed. Read more >>
14Jul
1908 Brands expands Pasta Jay’s sauces to Safeway, Costco
The popular pasta dishes of Italian eatery Pasta Jay’s Inc. can now be replicated at home for Safeway and Costco shoppers. The Boulder staple of more than 30 years will sell its pasta sauce in 100 Costco Wholesale Corp. and Safeways, a subsidiary of Albertsons Cos. Inc. Read more >>
11Jul
DOE funds 8 biomanufacturing projects
Today, the U.S. Department of Energy announced the selection of eight projects totaling over $5 million to conduct research and development (R&D) needed to accelerate the US biomanufacturing sector. Part of the Agile BioFoundry (ABF) consortium, these projects will leverage National Laboratory capabilities to address challenges in biomanufacturing - Kalion, Inc, of Milton, MA, will use machine learning and artificial intelligence to lower growth media production costs, increase productivity, and increase the overall commercial feasibility of biomanufacturing, with glucaric acid...
10Jul
Myomo launches MyoCare
Myomo announced today that it launched its MyoCare program for providing support to first-year users of its MyoPro powered brace.MyoCare offers expanded support to current and future clients who receive their MyoPro directly from the Cambridge, Mass.-based company, at no additional cost. Read more >>
09Jul
Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors
Corbus Pharmaceuticals, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the appointment of George Golumbeski, Ph.D., to its Board of Directors. Read more >>
08Jul
Pittsburgh biotech company wins funding for Covid-19 drug
Pittsburgh biotech company CytoAgents has received $250,000 from the Richard King Mellon Foundation to help develop its drug candidate to treat cytokine storm, a deadly complication of Covid-19 and other upper respiratory illnesses. CytoAgents has been working on phase I and phase II clinical trials for GP1681, its existing drug candidate that even before Covid-19 had treated the immune response that causes inflammation and respiratory distress for people with severe influenza. It received a $1.6 million grant from the National...
08Jul